Sedation, sucralfate, and antibiotic use are potential means for protection against early-onset ventilator-associated pneumonia

Clinical Infectious Diseases

Volumn 38, Issue 10, 2004, Pages 1401-1408

  Bornstain, C ^a   Azoulay, E ^a   De Lassence, A ^e   Cohen, Y ^f   Costa, M A ^b   Mourvillier, B ^g   Descorps Declere, A ^h   Garrouste Orgeas, M ^c   Thuong, M ⁱ   Schlemmer, B ^a   Timsit, J F ^d  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL TENON   (France)

^c SAINT JOSEPH HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e HÔPITAL LOUIS MOURIER   (France)

^f AVICENNE HOSPITAL   (France)

^g Medical Surgical ICU   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

ⁱ De la Fontaine Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; SUCRALFATE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONFIDENCE INTERVAL; EXTUBATION; FEMALE; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTECTION; RISK FACTOR; SCORING SYSTEM; SEDATION; SEX DIFFERENCE;

AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; SUCRALFATE; TIME FACTORS; VENTILATORS, MECHANICAL;

EID: 2442648869     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/386321     Document Type: Article

References (44)

1. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a national heart, lung, and blood institute working group. Am J Respir Crit Care Med 2003; 167: 1027-35.
2. Azoulay E, Moine P, Cohen Y, et al. Nosocomial pneumopathy acquired under mechanical ventilation: suspicion criteria, bacteriologic diagnosis, and remission criteria. Rev Pneumol Clin 2001; 57:380-90.
3. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-21.
4. Hubmayr RD, Burchardi H, Elliot M, et al. Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia - Chicago, Illinois, May 2002. Intensive Care Med 2002; 28:1521-36.
5. Ibrahim EH, Ward S, Sherman G, et al. A comparative analysis of patients with early-onset vs. late-onset nosocomial pneumonia in the ICU setting. Chest 2000; 117:1434-42.
6. Pettila V, Takkunen O, Varpula T, et al. Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study. Crit Care Med 2000; 28:3620-5.
7. Moine P, Timsit JF, De Lassence A, et al. Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study. Intensive Care Med 2002; 28:154-63.
8. Chastre J Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903.
9. Azoulay E, Adrie C, De Lassence A, et al. Determinants of postintensive care unit mortality: a prospective multicenter study. Crit Care Med 2003; 31:428-32.
10. Knaus WA, Draper EA, Wagner DR et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
11. Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system: a new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996; 276:802-10.
12. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-10.
13. de Lassence A, Alberti C, Azoulay E, et al. Impact of unplanned extubation and reintubation after weaning on nosocomial pneumonia risk in the intensive care unit: a prospective multicenter study. Anesthesiology 2002; 97:148-56.
14. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-56.
15. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-9.
16. Timsit JF, Misset B, Renaud B, et al. Effect of previous antimicrobial therapy on the accuracy of the main procedures used to diagnose nosocomial pneumonia in patients who are using ventilation. Chest 1995; 108:1036-40.
17. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122:179-86.
18. Kollef MH, Skubas NJ Sundt TM. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 1999; 116:1339-46.
19. Kunze K. Metabolic encephalopathies. J Neurol 2002; 249:1150-9.
20. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 2001; 248:929-34.
21. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24:1408-16.
22. Berrouane Y, Daudenthun I, Riegel B, et al. Early onset pneumonia in neurosurgical intensive care unit patients. J Hosp Infect 1998; 40: 275-80.
23. Baraibar J, Correa H, Mariscal D, et al. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 1997; 112:1050-4.
24. Akca O, Koltka K, Uzel S, et al. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus nonresistant bacteria. Anesthesiology 2000; 93:638-45.
25. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433-40.
26. Stevenson GW, Hall SC, Rudnick S, et al. The effect of anesthetic agents on the human immune response. Anesthesiology 1990; 72:542-52.
27. Wolach B, Sazbon L, Gavrieli R, et al. Early immunological defects in comatose patients after acute brain injury. J Neurosurg 2001; 94: 706-11.
28. Adnet F, Baud F. Relation between Glasgow Coma Scale and aspiration pneumonia. Lancet 1996; 348:123-4.
29. Kollef MH, Levy NT, Ahrens TS, et al. The use of continuous iv sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114:541-8.
30. Kress JP, Pohlman AS, O'Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-7.
31. Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27:2609-15.
32. Ewig S, Soler N, Gonzalez J, et al. Evaluation of antimicrobial treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations. Crit Care Med 2000; 28:692-7.
33. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134:298-314.
34. Gastinne H, Wolff M, Delatour F, et al. A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N Engl J Med 1992; 326:594-9.
35. Ferrer M, Torres A, Gonzalez J, et al. Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 1994; 120:389-95.
36. D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998; 316:1275-85.
37. Kollef MH. Selective digestive decontamination should not be routinely employed. Chest 2003; 123:464S-8S.
38. Sirvent JM, Torres A, El-Ebiary M, et al. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 1997; 155: 1729-34.
39. Ibrahim EH, Mehringer L, Prentice P, et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 2002; 26:174-81.
40. Montejo JC, Grau T, Acosta J, et al. Multicenter, prospective, randomized, single-blind study comparing the efficacy and gastrointestinal complications of early jejunal feeding with early gastric feeding in critically ill patients. Crit Care Med 2002; 30:796-800.
41. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med 1994; 120:653-62.
42. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: a randomized, controlled, single-blind study. Ann Intern Med 1994; 121:568-75.
43. Stack PE Thomas E. Pharmacobezoar: an evolving new entity. Dig Dis 1995; 13:356-64.
44. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000; 161:1942-8.